U.S. Markets closed

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.89+0.06 (+1.57%)
At close: 4:00PM EDT
People also watch
SPHSEBIOPBMDNVGNCYCC

Nymox Pharmaceutical Corporation

Bay & Deveaux Streets
Nassau
Bahamas

http://www.nymox.com

SectorHealthcare
IndustryDiagnostic Substances
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. Paul Averback M.D., DABPFounder, Chairman, Chief Exec. Officer and Pres75kN/A66
Mr. Erik DanielsenChief Financial Officer250kN/A54
Mr. Randall J. Lanham Esq.Gen. Counsel, Sec. and Director185kN/A53
Dr. Judith Fitzpatrick Ph.D.Exec.N/AN/A68
Dr. Suresh Kalbag M.D.Director of CMC OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company markets its products in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, The Bahamas.

Corporate Governance

Nymox Pharmaceutical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.